USPTO serial 79301368
H HISOAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 20, 2021
- Examiner
- LATTUCA, FRANK J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with H HISOAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zhejiang Hisoar Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhejiang Hisoar Pharmaceutical Co., Ltd.
Zhejiang Hisoar Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhejiang Hisoar Pharmaceutical Co., Ltd.
Zhejiang Hisoar Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhejiang Hisoar Pharmaceutical Co., Ltd.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Esters, namely, Clindamycin palmitate hydrochloride, Bifendate and beta-Methyl vinyl phosphate; ketones; industrial chemicals; diagnostic preparations, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; surface-active chemical agents for emulsification, suspension, wetting or resistant to adhesion, disinfection and bactericidal effect; leather-waterproofing chemicals | ACTIVE | — |
| 005 | Medicines for human purposes, namely, antibacterial, antihypertensive, antihyperglycemic, antipsychotic, antidepressants, anti fungal infection, and anti-HBV; pharmaceutical preparations, namely, antibacterial, antihypertensive, antihyperglycemic, antipsychotic, antidepressants, anti fungal infection, and anti-HBV; chemico-pharmaceutical preparations, namely, antibacterial, antihypertensive, antihyperglycemic, antipsychotic, antidepressants, anti fungal infection, and anti-HBV; drugs for medical purposes, namely, antibacterial, antihypertensive, antihyperglycemic, antipsychotic, antidepressants, anti fungal infection, and anti-HBV; antiparasitic preparations; antibacterial pharmaceuticals; feed supplements for veterinary purposes; medicines for veterinary purposes; chemical preparations for veterinary purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named H HISOAR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 6, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 17, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 17, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 20, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 20, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 4, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 4, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 14, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 14, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 31, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 31, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 1, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 1, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 19, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 18, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 15, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 8, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 4, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 1, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |